IN2014MN01936A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN01936A IN2014MN01936A IN1936MUN2014A IN2014MN01936A IN 2014MN01936 A IN2014MN01936 A IN 2014MN01936A IN 1936MUN2014 A IN1936MUN2014 A IN 1936MUN2014A IN 2014MN01936 A IN2014MN01936 A IN 2014MN01936A
- Authority
- IN
- India
- Prior art keywords
- cancer
- level
- getting
- risk
- female subject
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261608346P | 2012-03-08 | 2012-03-08 | |
| EP12158679 | 2012-03-08 | ||
| EP12165054 | 2012-04-20 | ||
| PCT/EP2013/054800 WO2013132089A2 (en) | 2012-03-08 | 2013-03-08 | A method for predicting the risk of getting cancer or diagnosing cancer in a female subject |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01936A true IN2014MN01936A (https=) | 2015-07-10 |
Family
ID=49117445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1936MUN2014 IN2014MN01936A (https=) | 2012-03-08 | 2013-03-08 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20150031144A1 (https=) |
| EP (1) | EP2823313B1 (https=) |
| JP (1) | JP6290795B2 (https=) |
| CN (1) | CN103308689B (https=) |
| IN (1) | IN2014MN01936A (https=) |
| RU (1) | RU2642623C2 (https=) |
| WO (1) | WO2013132089A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015101596A2 (en) | 2013-12-30 | 2015-07-09 | Oncoprevent Gmbh | Neurokinin-1 receptor antagonists for use in a method of prevention of cancer |
| CN104237535B (zh) * | 2014-09-30 | 2016-02-10 | 天津市泌尿外科研究所 | 神经降压素在诊断去势抵抗性前列腺癌神经内分泌化亚型和判断预后中的应用 |
| EP3002589A1 (en) | 2014-10-01 | 2016-04-06 | sphingotec GmbH | A method for stratifying a female subject for hormone replacement therapy |
| ES2781084T3 (es) * | 2015-02-27 | 2020-08-28 | Sphingotec Gmbh | Un método para predecir el riesgo de obesidad en un sujeto |
| KR102618553B1 (ko) * | 2022-08-31 | 2023-12-27 | 숙명여자대학교산학협력단 | 당뇨병 환자의 유방암 발병 예측 및 유방암 환자의 예후 예측용 바이오마커 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU634716B2 (en) | 1988-08-01 | 1993-03-04 | Ciba Corning Diagnostics Corp. | Method for detection of an analyte using acridinium esters and liposomes |
| US6596476B1 (en) * | 1989-12-22 | 2003-07-22 | Abbott Laboratories | Hepatitis C assay |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| RU2004109222A (ru) | 2001-08-30 | 2005-10-20 | Байорексис Фармасьютикал Корпорейшн (Us) | Слитые белки модифицированного трансферрина |
| WO2003103475A2 (en) | 2002-06-07 | 2003-12-18 | Dyax Corp. | Prevention and reduction of blood loss |
| WO2005040229A2 (en) | 2003-10-24 | 2005-05-06 | Avidia, Inc. | Ldl receptor class a and egf domain monomers and multimers |
| US20100028995A1 (en) | 2004-02-23 | 2010-02-04 | Anaphore, Inc. | Tetranectin Trimerizing Polypeptides |
| US20050233393A1 (en) * | 2004-02-27 | 2005-10-20 | Wynne-Edwards Katherine E | Dynamic hormone index as a biomarker for disease |
| US20060062729A1 (en) * | 2004-09-09 | 2006-03-23 | Carraway Robert E | Enhanced ligand binding to neurotensin receptors |
| US8278262B2 (en) | 2004-09-21 | 2012-10-02 | Biontech Ag | Use of microproteins as tryptase inhibitors |
| DE102005003687A1 (de) * | 2005-01-26 | 2006-07-27 | Sphingo Tec Gmbh | Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation |
| WO2007093373A2 (en) * | 2006-02-14 | 2007-08-23 | Università Degli Studi Di Siena | Branched multimeric peptides for tumor diagnosis and therapy |
| US8449864B2 (en) * | 2006-10-20 | 2013-05-28 | The Board Of Trustees Of The Leland Stanford Junior University | Neurotensin as a marker and therapeutic target for sepsis |
| WO2009044561A1 (ja) * | 2007-10-03 | 2009-04-09 | Shizuoka Prefecture | 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体 |
| DK2231860T3 (da) | 2007-12-19 | 2011-12-05 | Affibody Ab | Polypeptid afledt protein A og i stand til at binde PDGF |
| EP3785735A1 (en) | 2008-11-03 | 2021-03-03 | Molecular Partners AG | Binding proteins inhibiting the vegf-a receptor interaction |
| EP2374003B1 (en) | 2009-01-07 | 2015-03-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment, the prognostic assessment and the detection of breast cancer |
| MX2012002428A (es) | 2009-08-27 | 2012-09-12 | Covagen Ag | Compuestos de union il-17 y usos medicos de los mismos. |
| AU2010332932B2 (en) | 2009-12-14 | 2013-01-17 | Navigo Proteins Gmbh | Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin |
| RU2569745C2 (ru) | 2010-06-08 | 2015-11-27 | Пиерис АГ | Мутеины липокалина слезы, связывающие альфа il-4 r |
| CN103308670B (zh) * | 2012-03-08 | 2017-06-09 | 思芬构技术有限公司 | 用于预测对象患糖尿病和/或代谢综合征的风险的方法 |
| ES2676737T3 (es) * | 2012-10-02 | 2018-07-24 | Sphingotec Gmbh | Método para predecir el riesgo de contraer cáncer o para diagnosticar cáncer en un sujeto femenino |
-
2012
- 2012-10-08 CN CN201210585701.7A patent/CN103308689B/zh active Active
-
2013
- 2013-03-08 WO PCT/EP2013/054800 patent/WO2013132089A2/en not_active Ceased
- 2013-03-08 IN IN1936MUN2014 patent/IN2014MN01936A/en unknown
- 2013-03-08 JP JP2014560404A patent/JP6290795B2/ja active Active
- 2013-03-08 US US14/383,428 patent/US20150031144A1/en not_active Abandoned
- 2013-03-08 EP EP13710342.0A patent/EP2823313B1/en active Active
- 2013-03-08 RU RU2014140432A patent/RU2642623C2/ru active
-
2020
- 2020-12-22 US US17/131,008 patent/US20210109102A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013132089A3 (en) | 2014-02-20 |
| US20210109102A1 (en) | 2021-04-15 |
| JP6290795B2 (ja) | 2018-03-07 |
| EP2823313A2 (en) | 2015-01-14 |
| WO2013132089A2 (en) | 2013-09-12 |
| US20150031144A1 (en) | 2015-01-29 |
| JP2015512047A (ja) | 2015-04-23 |
| EP2823313B1 (en) | 2019-09-18 |
| RU2642623C2 (ru) | 2018-01-25 |
| CN103308689B (zh) | 2017-04-12 |
| CN103308689A (zh) | 2013-09-18 |
| WO2013132089A4 (en) | 2014-04-10 |
| RU2014140432A (ru) | 2016-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL270864A (en) | Identification of biomarkers on vesicles for diagnosis and prognosis of diseases and disorders | |
| IN2013CN01129A (https=) | ||
| EP4060048A3 (en) | Non-invasive diagnostic method for diagnosing bladder cancer | |
| EP3683320A3 (en) | Mirna fingerprint in the diagnosis of lung cancer | |
| WO2013084002A3 (en) | Method for detecting nucleosome adducts | |
| MX2020010947A (es) | Metodos de tratamiento de enfermedad de alzheimer. | |
| WO2014028884A3 (en) | Cancer diagnostics using biomarkers | |
| WO2014140933A3 (en) | Method for the prognosis and treatment of cancer metastasis | |
| WO2011015944A3 (en) | Use of free dna as an early predictor of severity in acute pancreatitis | |
| MX382266B (es) | Metodo para el diagnostico, pronostico y tratamiento de la metastasis de cancer de mama. | |
| MX2016012285A (es) | Tratamiento de cáncer con antagonista de c-met y correlación de estos con la expresión de hgf. | |
| IN2014MN01936A (https=) | ||
| SG10201808585TA (en) | Compositions and methods related to diagnosis of prostate cancer | |
| WO2014078468A3 (en) | Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent | |
| WO2014184679A3 (en) | Method for the prognosis and treatment of renal cell carcinoma metastasis | |
| PL2734636T3 (pl) | Bio-markery mikro-rna do identyfikacji ryzyka i/lub diagnozowania nowotworu płuc | |
| HK1220253A1 (zh) | 诊断前列腺癌症的方法 | |
| IN2014MN01940A (https=) | ||
| MX2017015700A (es) | Igfbp3 y sus usos. | |
| WO2012125805A3 (en) | Protein biomarkers for the diagnosis of prostate cancer | |
| MX377026B (es) | Biomarcadores para la progresión de enfermedades en melanoma. | |
| IN2015DN01646A (https=) | ||
| MA40636A (fr) | Procédés pour détecter le cancer de la prostate | |
| WO2012006394A3 (en) | Hmga2 as a biomarker for diagnosis and prognosis of ovarian cancer | |
| WO2016066862A3 (en) | A method for predicting the risk of obesity in a subject |